Back
Jaguar Health 10K Form
Sell
23
JAGX
Jaguar Health
Last Price:
1.03
Seasonality Move:
104.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JAGX News And Ratings
See the #1 stock for the next 7 days that we like better than JAGX
JAGX Financial Statistics
Sales & Book Value
| Annual Sales: | $9.76M |
|---|---|
| Cash Flow: | $-8.19M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.16 |
| Price / Book: | 0.57 |
Profitability
| EPS (TTM): | -37.93460 |
|---|---|
| Net Income (TTM): | $-35.67M |
| Gross Margin: | $7.72M |
| Return on Equity: | -439.92% |
| Return on Assets: | -67.25% |
Jaguar Health Earnings Forecast
Key Jaguar Health Financial Ratios
- The Gross Profit Margin over the past 10 years for JAGX is 79.13%.
- The Selling, General & Administrative Expenses for JAGX have been equal to 236.12% of Gross Profit Margin.
- The Research & Development expenses have been 190.51% of Revenue.
- The Interest Expense is -15.45% of Operating Income.
- The Net Earning history of JAGX is -423.11% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 8 years.
Jaguar Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | JAGX |
| CUSIP: | 47010C |
| Website: | jaguar.health |
Debt
| Debt-to-Equity Ratio: | 1.95 |
|---|---|
| Current Ratio: | 2.1 |
| Quick Ratio: | 0.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
JAGX Technical Analysis vs Fundamental Analysis
Sell
23
Jaguar Health (JAGX)
is a Sell
Is Jaguar Health a Buy or a Sell?
-
Jaguar Health stock is rated a Sell
The current Jaguar Health [JAGX] share price is $1.04. The Score for JAGX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.